Investigators from Glasgow University, Glasgow Royal Infirmary and Cork and Leiden Universities are starting the first study of the effects of pravastin, a medication widely prescribed to prevent heart attacks in people aged 70 and over. The study, being led by James Shepherd, Glasgow University's professor of pathological biochemistry, will enrol 5,500 patients from the United Kingdom, Ireland and the Netherlands.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to 罢贬贰’蝉 university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.